See higher levels in Ranbaxy, says Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "There are a lot of choices in pharmaceuticals. Divis Laboratories is an excellent chart. It is just willing to go make new highs. That is a stock we should be looking at."

He further added, "Yesterday’s Ranbaxy Laboratories’ price performance was remarkable, a big decline and finally a very strong close. So a new uptrend seems to be starting there. This is just two of them. I would say that the entire sector essentially is cheerful. We should not worry about valuations. The strong momentum is there."